Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

771
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
771
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

855
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
855
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

26
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
26

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeted Protein Degradation and Metabolic Inhibition as Complementary Therapeutic Strategies: TEAD PROTACs and NAT8L Inhibitors in Oncology.

ACS medicinal chemistry letters·2026
Same author

Degrading Immune Checkpoints and Coordinating Oncogenic Signaling: Emerging Strategies in Cancer Therapy.

ACS medicinal chemistry letters·2026
Same authorSame journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
Same authorSame journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same author

Acyclic Glutarimide PROTAC Precursors Enable Controlled Protein Degradation and Expand Cereblon Ligand Space.

ACS medicinal chemistry letters·2026
Same author

Selective Induction of Estrogen Receptor-Dependent Stress Signaling as a Therapeutic Strategy in Resistant Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 19, 2026

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

980

固体状態制御から予測精度へ:サイケデリック療法のための展開可能なエコシステムの構築

Anna C Renner1, Robert B Kargbo2

  • 1North Dakota State University, Fargo, North Dakota 58108-6050, United States.

ACS medicinal chemistry letters
|February 18, 2026
PubMed
まとめ
この要約は機械生成です。

サイケデリック薬の開発は,新しい治療システムで前進しています. イノベーションには,薬剤の安定性を最適化し,AIを使用して患者の反応を予測し,サイケデリック医学における主要な課題に取り組むことが含まれています.

さらに関連する動画

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

6.7K
Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

8.6K

関連する実験動画

Last Updated: Feb 19, 2026

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

980
Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

6.7K
Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

8.6K

科学分野:

  • 薬理学 薬理学とは
  • 神経科学は神経科学である.
  • バイオテクノロジー バイオテクノロジー

背景:

  • サイケデリック薬の開発は,伝統的な分子的および経験的アプローチを超えて進化しています.
  • 翻訳的研究は,製造,安定性,治療効果を予測する点でボトルネックに直面しています.

研究 の 目的:

  • 2つの特許出願を通じて,サイケデリック療法システムの最近の進歩を強調する.
  • サイケデリック医学における翻訳的な課題を克服するための革新的な戦略を実証する.

主な方法:

  • リサーガミドアナログの固体状態最適化により,製造可能性と安定性が向上します.
  • サイケデリック療法に対する患者の反応を予測するために,機械学習主導の神経生理学的バイオマーカーの適用.

主要な成果:

  • 特許出願は,安定した,製造可能なサイケデリック薬物製剤の作成における進歩を明らかにしています.
  • 機械学習を用いた予測バイオマーカーの開発は,パーソナライズされたサイケデリック治療のアプローチを強化します.

結論:

  • サイケデリック医学は,統合された治療システムに向かって進歩しています.
  • これらの進歩は,重要な製造と患者の階層化の課題に対処し,より広範な臨床応用への道を開きます.